Aldosterone and Vascular Disease in Diabetes Mellitus

Completed · Not applicable · Has a placebo group

Conditions studied: Diabetes Mellitus, Endothelial Dysfunction, Albuminuria

In brief

Specific aims for this proposal are to determine in patients with diabetes mellitus the effects of an aldosterone receptor antagonist on: 1. Coronary microvascular function assessed by MRI perfusion reserve, 2. Endothelial dysfunction assessed by brachial artery reactivity studies, and 3. Inflammation assessed by blood measurements of c-reactive protein (CRP), monocyte chemoattractant protein-1 (MCP-1), and plasminogen activator inhibitor-1 (PAI-1).

Key facts

Study ID
NCT00214825
Run by
Brigham and Women's Hospital
People needed
46
Starts
2003-08-01
Expected to finish
2006-03-01
Last updated by the study team
2008-01-03

Who can join

Age: 21 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.